Related Experiment Videos
Systemic lupus erythematosus: two patients treated with danazol
British Medical Journal (Clinical Research Ed.)
|May 15, 1982
Summary
Danazol treatment improved premenstrual flares in two women with systemic lupus erythematosus. Further research is needed to confirm hormonal regulation
Area of Science:
- Rheumatology
- Endocrinology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
- Premenstrual exacerbations of SLE symptoms are observed in some patients.
- Hormonal influences on SLE pathogenesis are increasingly recognized.
Observation:
- Two female patients with SLE experienced significant premenstrual disease flares.
- These patients were treated with danazol, a synthetic androgen.
Findings:
- Danazol administration led to marked clinical improvement in both patients.
- The treatment appeared to mitigate the premenstrual worsening of SLE symptoms.
Implications:
- Danazol may represent a potential therapeutic option for managing cyclical SLE flares.
- Larger studies are warranted to validate the efficacy of hormonal modulation in SLE.
- This finding could open new avenues for personalized SLE treatment strategies.